Charan Thej

825 total citations
20 papers, 614 citations indexed

About

Charan Thej is a scholar working on Surgery, Molecular Biology and Genetics. According to data from OpenAlex, Charan Thej has authored 20 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 10 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in Charan Thej's work include Mesenchymal stem cell research (10 papers), Extracellular vesicles in disease (4 papers) and Diabetic Foot Ulcer Assessment and Management (4 papers). Charan Thej is often cited by papers focused on Mesenchymal stem cell research (10 papers), Extracellular vesicles in disease (4 papers) and Diabetic Foot Ulcer Assessment and Management (4 papers). Charan Thej collaborates with scholars based in India, United States and Malaysia. Charan Thej's co-authors include Anish Sen Majumdar, Sudha Balasubramanian, Pawan Kumar Gupta, Mathiyazhagan Rengasamy, Pachaiyappan Viswanathan, Anoop Chullikana, Vivek Pandey, Vikas Agarwal, Shrikant Wagh and Parvathy Venugopal and has published in prestigious journals such as Circulation Research, Theranostics and Arthritis Research & Therapy.

In The Last Decade

Charan Thej

20 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charan Thej India 10 393 237 197 194 135 20 614
Pachaiyappan Viswanathan India 7 318 0.8× 163 0.7× 188 1.0× 107 0.6× 132 1.0× 10 451
Anoop Chullikana India 6 532 1.4× 341 1.4× 345 1.8× 233 1.2× 202 1.5× 9 827
Rosanna Ferreira France 8 430 1.1× 197 0.8× 439 2.2× 154 0.8× 198 1.5× 10 750
Preeti Malladi United States 8 360 0.9× 208 0.9× 183 0.9× 182 0.9× 73 0.5× 10 625
M.J. Leijs Netherlands 7 296 0.8× 154 0.6× 224 1.1× 86 0.4× 111 0.8× 11 473
Pan Pan Chong Malaysia 8 203 0.5× 164 0.7× 165 0.8× 116 0.6× 93 0.7× 13 454
Martin Vaegler Germany 13 314 0.8× 252 1.1× 79 0.4× 121 0.6× 138 1.0× 28 630
Sophie Domergue France 7 330 0.8× 240 1.0× 271 1.4× 92 0.5× 156 1.2× 16 658
Pablo Bora Czechia 7 225 0.6× 160 0.7× 60 0.3× 131 0.7× 63 0.5× 7 456
Arjunan Subramanian Singapore 13 508 1.3× 267 1.1× 65 0.3× 243 1.3× 57 0.4× 20 712

Countries citing papers authored by Charan Thej

Since Specialization
Citations

This map shows the geographic impact of Charan Thej's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charan Thej with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charan Thej more than expected).

Fields of papers citing papers by Charan Thej

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charan Thej. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charan Thej. The network helps show where Charan Thej may publish in the future.

Co-authorship network of co-authors of Charan Thej

This figure shows the co-authorship network connecting the top 25 collaborators of Charan Thej. A scholar is included among the top collaborators of Charan Thej based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charan Thej. Charan Thej is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Magadum, Ajit, Vandana Mallaredy, Rajika Roy, et al.. (2025). Phosphoserine aminotransferase 1 promotes serine synthesis pathway and cardiac repair after myocardial infarction. Theranostics. 15(15). 7219–7241. 1 indexed citations
2.
Cheng, Zhongjian, May Truongcao, Vandana Mallaredy, et al.. (2025). Muscle-specific miR-499-5p delivered by small extracellular vesicles impairs endothelial function and ischemic hindlimb recovery in diabetic mice. Cardiovascular Diabetology. 24(1). 273–273. 1 indexed citations
3.
Mallaredy, Vandana, Rajika Roy, Zhongjian Cheng, et al.. (2024). Tipifarnib Reduces Extracellular Vesicles and Protects From Heart Failure. Circulation Research. 135(2). 280–297. 10 indexed citations
4.
Thej, Charan, Rajika Roy, Zhongjian Cheng, et al.. (2024). Epigenetic mechanisms regulate sex differences in cardiac reparative functions of bone marrow progenitor cells. npj Regenerative Medicine. 9(1). 17–17. 7 indexed citations
5.
Joladarashi, Darukeshwara, Charan Thej, Vandana Mallaredy, et al.. (2024). GPC3-mediated metabolic rewiring of diabetic mesenchymal stromal cells enhances their cardioprotective functions via PKM2 activation. iScience. 27(10). 111021–111021. 2 indexed citations
6.
Thej, Charan & Raj Kishore. (2024). Epigenetic regulation of sex dimorphism in cardiovascular health. Canadian Journal of Physiology and Pharmacology. 102(9). 498–510. 2 indexed citations
7.
Huang, Grace, Zhongjian Cheng, Chunlin Wang, et al.. (2022). Diabetes impairs cardioprotective function of endothelial progenitor cell-derived extracellular vesicles via H3K9Ac inhibition. Theranostics. 12(9). 4415–4430. 34 indexed citations
8.
Thej, Charan, Sudha Balasubramanian, Mathiyazhagan Rengasamy, et al.. (2021). Human bone marrow-derived, pooled, allogeneic mesenchymal stromal cells manufactured from multiple donors at different times show comparable biological functions in vitro, and in vivo to repair limb ischemia. Stem Cell Research & Therapy. 12(1). 279–279. 10 indexed citations
9.
10.
Gupta, Pawan Kumar, Sanjay C Desai, Arunanshu Behera, et al.. (2021). Phase IV Postmarketing Surveillance Study Shows Continued Efficacy and Safety of Stempeucel in Patients with Critical Limb Ischemia Due to Buerger's Disease. Stem Cells Translational Medicine. 10(12). 1602–1613. 13 indexed citations
11.
12.
Rengasamy, Mathiyazhagan, Gurbind Singh, Bentham Science Publisher SiddikUzzaman, et al.. (2017). Transplantation of human bone marrow mesenchymal stromal cells reduces liver fibrosis more effectively than Wharton’s jelly mesenchymal stromal cells. Stem Cell Research & Therapy. 8(1). 143–143. 32 indexed citations
13.
Balasubramanian, Sudha, et al.. (2017). Evaluation of the Secretome Profile and Functional Characteristics of Human Bone Marrow Mesenchymal Stromal Cells-Derived Conditioned Medium Suggest Potential for Skin Rejuvenation. Journal of Cosmetics Dermatological Sciences and Applications. 7(1). 99–117. 9 indexed citations
14.
15.
Gupta, Pawan Kumar, Anoop Chullikana, Mathiyazhagan Rengasamy, et al.. (2016). Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel®): preclinical and clinical trial in osteoarthritis of the knee joint. Arthritis Research & Therapy. 18(1). 301–301. 252 indexed citations
16.
Gupta, Pawan Kumar, Anoop Chullikana, Soaham Desai, et al.. (2016). Administration of Adult Human Bone Marrow-Derived, Cultured, Pooled, Allogeneic Mesenchymal Stromal Cells in Critical Limb Ischemia Due to Buerger's Disease: Phase II Study Report Suggests Clinical Efficacy. Stem Cells Translational Medicine. 6(3). 689–699. 60 indexed citations
17.
Majumdar, Anish Sen, Sudha Balasubramanian, Charan Thej, et al.. (2015). A First of its kind Phase II clinical trial in critical limb ischemia patients using bone marrow derived, pooled, allogeneic mesenchymal stromal cells (Stempeucel®). Cytotherapy. 17(6). S84–S84. 3 indexed citations
18.
Majumdar, A. S., Shankar Balasubramanian, Charan Thej, et al.. (2014). Allogeneic mesenchymal stem cell therapy for knee osteoarthritis: safety and efficacy results of a randomized, double blind, phase 2, placebo controlled, dose finding study. Cytotherapy. 16(4). S105–S105. 4 indexed citations
19.
Venugopal, Parvathy, Suresh Kannan, Charan Thej, et al.. (2014). Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton’s jelly derived mesenchymal stem cells? A comparative study. Stem Cell Research & Therapy. 5(4). 88–88. 85 indexed citations
20.
Balasubramanian, Sudha, Charan Thej, Parvathy Venugopal, et al.. (2013). Higher propensity of Wharton's jelly derived mesenchymal stromal cells towards neuronal lineage in comparison to those derived from adipose and bone marrow. Cell Biology International. 37(5). 507–515. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pachaiyappan Viswanathan Breakdown of academic impact, for papers by Anoop Chullikana Breakdown of academic impact, for papers by Rosanna Ferreira Breakdown of academic impact, for papers by Preeti Malladi Breakdown of academic impact, for papers by M.J. Leijs Breakdown of academic impact, for papers by Pan Pan Chong Breakdown of academic impact, for papers by Martin Vaegler Breakdown of academic impact, for papers by Sophie Domergue Breakdown of academic impact, for papers by Pablo Bora Breakdown of academic impact, for papers by Arjunan Subramanian
Rankless by CCL
2026